Preprint
Review

This version is not peer-reviewed.

Sex Differences in the Associations among Early Life Adversity, Inflammation, and Cognition

A peer-reviewed article of this preprint also exists.

Submitted:

20 December 2024

Posted:

23 December 2024

You are already at the latest version

Abstract
Early life adversity (ELA) has long been recognized to negatively impact a variety of health outcomes, with increasingly recognized long-term implications for neurocognitive function. ELA may affect the brain through multiple mechanisms, including chronic inflammation. One potential moderator of the pathway from ELA to neuroinflammation to cognitive dysfunction is sex. ELA may leave females potentially even more vulnerable to cognitive impairment in later life. This review discusses the influence of ELA on cognitive function across much of the lifespan, how inflammation is implicated in this process, and the current state of knowledge regarding sex differences in these relationships. We conclude with a discussion of unanswered questions and suggestions for future research, including the incorporation of genetic data.
Keywords: 
;  ;  ;  

1. Introduction

Early life adversity (ELA) encompasses not only trauma and other adverse childhood experiences (ACEs) but additional significant stressors such as financial hardship, neighborhood deprivation, and racism [1,2,3]. Data from the Behavioral Risk Factor Surveillance System indicates that between 2001 and 2020, greater than 63% of adults were exposed to at least one adverse experience in childhood, and 17.3% were exposed to four or more [4]. Recent data indicates that before age four approximately one in five individuals have experienced adversity, with one in eight having at least two adverse experiences. These numbers increase when additional factors encompassing ELA are considered.
ELA has long been recognized as a risk factor for poor physical and mental health outcomes [5]. A meta-analysis conducted on adults with at least four ACEs revealed stronger associations with mental health outcomes (e.g., mental illness, drug and alcohol abuse, suicide) than physical health outcomes (e.g., heart disease, cancer, diabetes) [6]. Multiple mechanims to account for these associations have been proposed, including the role of inflammation, and extensively discussed in previous reviews [2,7]. Increasingly, long-term negative impacts on cognition are also being recognized in a growing body of evidence, with most studies finding some relationship between ELA and cognition. However, sex is often not modeled in human studies on this topic. This review will therefore discuss the influence of ELA on cognitive function across the lifespan, how inflammation is implicated in this process, and the current state of knowledge regarding sex differences in these relationships.

2. Early Life Adversity’s Impact on Cognition

2.1. In Childhood and Adolescence

In children and adolescents, some of the most consistent and strongest findings regarding the impact of ELA on cognition are related to the effects of childhood maltreatment and other interpersonal traumas on increased risk for cognitive delay, as well as low intelligence, attention, and executive function when compared to healthy controls [8,9,10,11,12,13]. Impacts on processing speed have also been found [11]. Findings from studies of memory in youth with trauma histories are inconsistent but generally show that trauma-exposed youth perform worse on measures of learning and memory than healthy controls [8,12,14]. These cognitive effects vary with severity and number of posttraumatic stress symptoms, and duration of maltreatment [8,13]. Deprivation, including through institutionalization for extended periods, also confers risk for deficits on test of intelligence; academic abilities; and neuropsychological tests of attention, working memory, language, memory, inhibitory control, and other executive functions [15,16,17,18,19,20].
However, the connection between ELA and cognition is far from straightforward. The degree of these cognitive deficits may also relate to developmental timing or class of adversity (i.e., deprivation versus threat) [12,18,21]. Yet, findings regarding onset of trauma related to cognitive outcomes in youth are variable [12,13]. Furthermore, some studies have found that cognitive ability prior to ELA largely accounted for the relationship between ELA and cognitive function [22], and recent evidence from a large longitudinal cohort suggest that mental health may mediate the association between early adversity and certain cognitive functions in later childhood [23]. Findings regarding cognitive outcomes in adults with ELA are similar and described below.

2.2. In Adulthood

Most conducted studies on this topic using data from longitudinal cohorts find a negative relationship between ELA and cognition in adulthood. Such studies have typically found that individuals with higher numbers of ACEs are more likely to experience cognitive dysfunction in both early adulthood and later in life [24,25,26,27,28,29]). Similarly, in a longitudinal cohort of females, more severe and more frequent sexual abuse were more strongly associated with lower scores on measures of cognition in mid-life [30]. The most consistent findings from these studies relate to memory and executive function, though psychomotor speed and attention are also implicated. Few studies report findings of better cognition related to ELA [31].
Cross-sectional studies indicate similar findings in terms of the domains impacted in adults. Examples include college students exposed to sexual abuse in childhood (poorer memory and inhibitory control as compared to health controls [32]), in early and middle adults exposed to multiple ACEs (worse executive function [33]), and in adults exposed to early food insecurity (poorer cognition [34]). However, cross sectional studies have not always found a relationship between number of ACEs and cognitive function [35]. Others present mixed findings, with some ACEs (e.g., physical abuse, sexual abuse) negatively impacting cognition and different ACEs exhibiting the opposite effect [36,37,38].
Other studies have found the effect of ELA on cognition mediated and moderated by additional factors. For example, education has regularly been cited as a mediating factor in the link between ACEs, early deprivation, socioeconomic disadvantage in early life, and cognitive outcomes in later life [25,39,40,41]. Other investigations have not found that demographic factors account for such findings [29]. Depression and frequent distress have also been found to mediate, and familial risk for mental illness has been found to moderate, the effect of ELA on cognition in adulthood [42,43,44,45]. Another identified moderator is social isolation [46].
Studies using a life course stressor approach generally find evidence to support that both stressors in childhood and adulthood (recent and remote) are associated with lower baseline levels of concentration, memory, processing speed, and/or and executive function, but have not always found evidence for faster rate of decline [24,40,47]. In one longitudinal cohort study, a faster decline in cognition in older adulthood over a ten-year period was only observed for individuals with ACEs and depression, as opposed to ACEs and no depression [48]. Others have found steeper decline in only certain cognitive abilities related to early life adversity [28,49], or related to increasing numbers of deprivation-related ACES but not threat-related ACEs [46]. One study found less decline in executive function in individuals with higher numbers of ACEs and no significant association between number of ACEs and baseline cognitive function [50].
Finally, there are trends related to certain ELAs across studies. Maltreatment and abuse, poverty and socioeconomic disadvantage, food insecurity, and parental death most consistently show relationships or show the strongest relationships with cognitive outcomes [27,28,32,39,41].

2.3. Summary

Across the youth and adult literature, there are clear trends. One is a dose-response relationship, with increased severity, frequency, duration, and numbers of ACEs generally negatively related to cognitive outcomes. Other similarities include the notion that baseline cognitive function may play a role and the mediating role of mental health factors. Few published studies have reported on no relationship or a positive relationship between ELA and cognition in youth and adults. Differences in the child and adult literature include memory more consistently shown as impacted in adult versus child samples.

3. Inflammation as a Potential Mediator

Questions remain as to the underlying biological processes that trigger brain changes leading to cognitive dysfunction in the ELA-exposed population. In fact, ELA may affect the brain through multiple mechanisms. The mechanism focused on in this paper is chronic inflammation. Although this has been extensively reviewed in this special issue as well as elsewhere [51], it deserves mention here as a segue into sex differences.

3.1. The Immune Response, Inflammation, and Hypothalamic-Pituitary-Adrenal (HPA) Axis Function

The immune response involves the binding of pathogen recognition receptors, not only to pathogen-associated molecular patterns such as those from viruses and bacteria, but to excessive levels of stress hormones resulting from ELA [52]. This initiates a cascade of events that lead to the recruitment and activation of various immune cells, such as phagocytes and natural killer cells, to target pathogens and excessive levels of stress hormones. This process is mediated by inflammatory cytokines and chemokines [53].
The HPA axis plays a crucial role in modulating inflammatory responses through its primary effector, cortisol. Upon activation by various stressors, including inflammatory stimuli, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH). ACTH then triggers the adrenal cortex to produce glucocorticoids, primarily cortisol [54]. Cortisol exerts potent anti-inflammatory effects by suppressing pro-inflammatory cytokine production, inhibiting leukocyte trafficking, and promoting the resolution of inflammation [55]. This feedback mechanism serves to prevent excessive or prolonged inflammatory responses that could lead to tissue damage or chronic inflammatory conditions. However, prolonged or repeated activation of the HPA axis, as seen in a chronic stress situation such as ELA, can lead to glucocorticoid resistance and dysregulation of the inflammatory response, potentially contributing to the development of various inflammatory disorders [56].
Conversely, inflammatory processes can significantly influence HPA axis function, creating a bidirectional relationship between these two systems. Pro-inflammatory cytokines, such as interleukin-1β (IL 1-β), tumor necrosis factor-α, and interleukin-6 (IL-6), can activate the HPA axis at multiple levels, including direct stimulation of CRH and ACTH release [57]. As indicated above, although this is an important adaptive response to acute inflammation, in conditions of chronic inflammation, persistent cytokine elevation can lead to HPA axis dysregulation, characterized by blunted cortisol responses to stress and aberrant reactivity [58,59]. This dysregulation can further exacerbate inflammatory processes, creating a potential feedback loop that may contribute to the pathogenesis of various stress-related and inflammatory disorders [60].

3.2. Evidence for ELA’s Relationship to Inflammation

Multiple early life stressors have been shown to lead to inflammation through both indirect and direct means. This includes childhood trauma. In one study, ACEs at age 7 years were positively associated with IL-6 at age 10, and ACEs at age 8 were positively associated with a CRP at age 15 after adjusting for CRP at age 10 [61]. However, a meta-analysis on the relationship between ELA and inflammation in children and adolescents found small effect sizes for CRP and IL-6 [62]. Authors cautioned that the small number of studies included for analysis were highly heterogenous.
Childhood trauma has been variously linked to inflammation in adulthood. A meta-analysis of 16,870 participants found that compared to adults without a history of childhood trauma, those with such a history had significantly higher levels of C-reactive protein (CRP), TNF-alpha, and IL-6 [63]. An updated meta-analysis did not find an association between childhood trauma and TNF-alpha and found differential links between certain childhood traumas and CRP and IL-6 [64]. The authors noted the potential for other variables at play, with some populations at higher risk for chronic inflammation, and suggested sex as a potential mediator worthy of future investigation. The strength of these associations also appears to increase over time across various early life adversities [65].
Specific forms of childhood adversity have also been tied to elevated inflammatory markers. Norton found a significant association between childhood experiences of family death and elevated levels of high-sensitivity CRP in later life [66]. Additionally, adolescents exposed to greater levels of peer victimization demonstrated increased levels of IL-6 and IL-1β [67]. Other research has suggested that victims of different types of abuse have shown varied inflammatory responses: physical abuse was associated with IL-2R, sexual abuse with IL-1β, and emotional abuse with IL-6 [64,68,69,70]. Adolescents exposed to community violence, observed in neighborhoods with high crime rates and poverty, evidenced higher levels of the proinflammatory markers CD14/CD16 in comparison to peers living in more stable environments [71]. Similar to peer victimization findings, the accumulation of social adversities, such as financial hardship, correlated with increased levels of CRP and other inflammatory markers [72]. Collectively, these findings highlight the links between ELA and inflammation and suggest that the biological embedding of stress can have lasting consequences on health through mechanisms involving inflammatory processes.

3.3. Impact on Cognition

Damaging states caused by prolonged stress include neuroinflammation and dysregulated brain network integrity [65,73,74]. Dysregulation of the HPA axis resulting from maltreatment impacts brain development, including in the prefrontal cortex and hippocampus, and neuroinflammation may be linked with cognitive impairment in later life partly through altered adult hippocampal neurogenesis [51,75,76]. Indeed, inflammation has been shown to play a mediating role in the relationship between ELA and cognitive function in later life, especially those involving prefrontal and hippocampal processes, in cross-sectional investigations [77]. For example, Davis et al. found that IL-6 mediated the negative relationship between childhood abuse and global cognitive performance in later life [78]. Allostatic load, of which inflammatory cytokines are components, has also been show to mediate the relationship between ELA and executive function in females in later life [79]; however, a prospective cohort study did not find this mediation effect [80].

3.4. Summary

Findings suggest that although the inflammatory response initiated by early adversities may disrupt neurodevelopmental processes crucial for cognitive functioning, additional variables are likely at play. One potential moderator is sex.

4. Sex Differences

4.1. In Cognitive Outcomes Following ELA

Many studies of the impact of ELA on cognition in adulthood do not model sex differences. Nevertheless, some evidence suggests that the impact of ELA on cognitive outcomes may differ between adult males and females. Studies that explicitly model sex differences have found that females who experience ELA, including abuse, demonstrated worse processing speed and delayed recall scores than males [27,41,45]. A longitudinal cohort study found that females raised in households with socioeconomic disadvantage exhibited more accelerated decline in delayed recall than males [41]. Another study found that ELA worsened performances on measures of learning for females but improved performance for males [81]. Wang et al. found that ACEs were more detrimental to females than males in that they increased depression symptoms and decreased cognitive function for each additional ACE experienced [45]. Some studies have modeled sex but not the interaction of sex and ELA; therefore, although they may report on whether there is a main effect of sex on cognition, how this interacts with trauma in such studies remains unknown. One exception was a longitudinal study which found no interaction between ACEs and sex in predicting memory performance or decline over time [47].
Although the above findings, taken together, suggest that adult females may be more vulnerable to the cognitive consequences of ELA, particularly in the learning and memory domain, research in youth indicates either no difference between male and female children [82] or that young males may be more susceptible to certain cognitive impairments following ELA. In a study examining the effect of institutionalization on cognition in childhood, sex did not modify the main effect of group on cognition [18]. In a meta-analysis on the effect of trauma exposure on executive function in youth, sex was not a moderator. Neither did sex interact with exposure to intimate partner violence between parents to predict memory performance in children [83]. The finding of lower IQ and visual memory among youth exposed to abuse and neglect versus those not exposed did not differ by sex in another study [84]. Yet, a longitudinal study found that boys from low-income backgrounds showed greater declines in working memory capacity during childhood compared to girls from similar socioeconomic circumstances [85]. Similarly, a meta-analysis found that there was a smaller effect of threat ACEs on working memory in children and adolescents in studies with a greater proportion of females [21].
These findings highlight the complexity of sex differences in the relationship between ELA and cognitive outcomes, suggesting that vulnerability may depend on the specific type of adversity, the cognitive domain being assessed, and the developmental period of those being assessed.

4.2. In Immune and Inflammatory Response

Largely due to the influence of sex hormones and evolutionary adaptations related to reproduction, the female immune system exhibits several distinct characteristics compared to that of males. The X chromosome also plays a crucial role in shaping the female immune system. Many genes involved in immune function are located on the X chromosome, and the presence of two X chromosomes in females can lead to increased expression of these immune-related genes. Furthermore, the process of X-chromosome inactivation, where one X chromosome is randomly silenced in each cell, can create a mosaic effect in females, potentially providing a broader range of immune responses. Generally higher immune reactivity in females is also attributable to the effects of estrogen, which stimulates the production of antibodies and promotes the activity of various immune cells [86,87]. As a result, females typically mount stronger and faster immune responses to pathogens and vaccines.
Another difference lies in the cyclical nature of the female immune system, which fluctuates throughout the menstrual cycle, and with pregnancy and menopause. For example, during the follicular phase of the menstrual cycle, when estrogen levels are high, the immune system is more active and responsive. Additionally, the female immune system undergoes significant changes during pregnancy, mediated by increases in estrogen and progesterone, to prevent rejection of the fetus while maintaining protection against pathogens. This is associated with a decrease in pro-inflammatory cytokines. Contrary to this, the decline in estrogen during menopause can lead to increased inflammatory markers [88].
Heightened immunity, genetic differences, and genetic diversity offer females greater protection against and an evolutionary advantage in fighting off a wider variety of pathogens, but also increases their susceptibility to inflammatory illnesses [87]. Furthermore, the cyclic variation in immune function can affect a woman's susceptibility to infections and susceptibility to immune related illnesses at different points in her menstrual cycle and her life.

4.3. In Relationships among ELA, Inflammation, and Cognition

Although the Baumeister et al. meta-analysis did not find a moderating effect of sex on the relationship between ELA and inflammatory markers, when sex differences are found in the relationships among these factors, they are found for females [63]. Two studies found a longitudinal association between ELA and CRP for females versus men [89,90]. Furthermore, in the D’Amico et al. study, the mediating role of allostatic load in the relationship between ELA and executive function was found only for females [79].
Even though inflammatory markers are only one component of allostatic load, mechanisms underlying any sex differences in ELA-related cognitive dysfunction may involve complex interactions between sex hormones, stress hormones, the inflammatory response, and neurodevelopmental processes [79,91]. Doom and Gunnar suggested that sex differences in stress reactivity and regulation during different points in development might contribute to differential vulnerability to ELA-induced cognitive dysfunction, noting how the stress response between the sexes becomes more pronounced at puberty [92]. Furthermore, while estrogen generally enhances immune function leading to increased reactivity and production of inflammatory cytokines, estrogen also has neuroprotective effects [93]. The decline of estrogen during menopause may increase the risk of cognitive decline, a process potentially compounded by a brain already vulnerable due to the cognitive effects of early life adversity [94]. Thus, ELA may leave females potentially even more vulnerable to cognitive impairment and developing neurocognitive disorders in later life.

5. Conclusions and Future Directions

The picture that seems to come together based on all of the above reviewed literature is that individuals assigned male at birth may be more vulnerable to the cognitive effects of ELA in childhood, whereas the effects for females become more pronounced with time. Females appear to be more vulnerable in later life, especially when considering effects on memory. This may be due to differential immune and inflammatory systems of females and associated with a proposed incubation effect, in which there is a prolonged glucocorticoid response to stressors experienced during adolescence that is not fully manifested until adulthood [95].
Indeed, chronic inflammation has been tied to ELA. Neuroinflammation, which can be caused by chronic inflammation, has been associated with cognitive decline and neurodegenerative diseases such as Alzheimer disease (AD), which is more common in females [96]. Although this is likely for a variety of factors, declines in estrogen during menopause and heightened immune reactivity in females could potentially contribute to increased neuroinflammation under certain conditions including ELA. However, unanswered questions remain.
For example, the literature reviewed suggests that different types of ELA (e.g., abuse, neglect, socioeconomic adversity) might have distinct cognitive and inflammatory outcomes. Further research is required to further delineate these differences and investigate them by sex, potentially leading to more targeted interventions. More longitudinal studies are needed to track relationships between ELA, inflammation, and cognitive dysfunction over time to examine how these relationships evolve based on age and sex. This requires not only capturing different dimensions of ELA systematically but jointly and consistently assessing multiple domains of cognition.
Understanding how genetic vulnerability to cognitive decline or epigenetic changes might influence the ELA-cognition relationship, particularly in how they interact with sex and inflammation, could also provide new avenues for personalized medicine. For example, worse attention and working memory have been found in females with childhood trauma and the ApoE4 allele versus those with only the ApoE4 allele or a history of childhood trauma alone [97]. APOE4, a protein associated with higher risk for developing AD (particularly in females) causes an increased proinflammatory response through heightened glial activity [96,98]. A question remains as to whether ELA contributes to this inflammatory cascade synergistically. The FKBP5 gene is also pro-inflammatory, and its expression increases with age. This gene regulates glucocorticoid receptor function and encodes FKBP51, the latter of which regulates tau (another protein implicated in AD) [99]. At least in mice, FKBP5’s expression is also increased with early life adversity and may have a sex-dimorphic influence [99,100]. This gene has also been shown to interact with early life adversity to increase a host of psychiatric symptoms in humans [101,102].
Ultimately, further understanding sex-specific differences in the link between early life adversity, inflammation, and cognition is crucial for developing targeted interventions and support strategies for individuals who have experienced early life adversity.

Conflicts of Interest

Erin Logue has reported no biomedical financial interests or potential conflicts of interest. Charles B. Nemeroff, in the last three years, served as a consultant to AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., EcoR1, GoodCap Pharmaceuticals, Inc., Senseye, Clexio, EmbarkBio, SynapseBio, BioXcel Therapeutics. He is a stockholder with Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Precisement Health, Relmada Therapeutics. He has served on advisory boards for ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., Sage. He has served on the Board of Directors for Gratitude America, ADAA, Lucy Scientific Discovery, Inc. He holds the following patents: Method and devices for transdermal delivery of lithium (US 6375,990B1); Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7148,027B2).

References

  1. Ferlitti, V.J.; Anda, R.F.; Nordenberg, D.; Williamson, D.F.; Spitz, A.M.; Edwards, V.; Koss, M.P.; Marks, J.S. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998, 14, 245–258. [CrossRef]
  2. Lopez, M.; Ruiz, M.O.; Rovnaghi, C.R.; Tam, G.K.; Hiscox, J.; Gotlib, I.H.; Barr, D.A.; Carrion, V.G.; Anand, K.J.S. The social ecology of childhood and early life adversity. Pediatr Res 2021, 89, 353–367. [CrossRef]
  3. Adverse childhood experiences international questionnaire (ACE-IQ). Available online: https://www.who.int/publications/m/item/adverse-childhood-experiences-internationalquestionnaire-(ace-iq) (accessed October 15 2024).
  4. Violence Prevention. Available online: https://www.cdc.gov/violenceprevention/aces/ace-brfss.html (accessed October 15 2024).
  5. Nemeroff, C.B. Paradise lost: The neurobiological and clinical consequences of child.
  6. abuse and neglect. Neuron 2016, 89, 892–909. [CrossRef]
  7. Hughes, K.; Bellis, M.A.; Hardcastle, K.A.; Sethi, D.; Butchart, A.; Mikton, C.; Jones, L.; Dunne, M.P. The effect of multiple adverse childhood experiences on health: A systematic review and meta-analysis. Lancet Public Health 2017, 2, e356–e366. [CrossRef]
  8. Lippard, E.T.C.; Nemeroff, C.B. Going beyond risk factor: Childhood maltreatment and associated modifiable targets to improve life-long outcomes in mood disorders. Pharmacol Biochem Behav 2022, 215, 173361. [CrossRef]
  9. Kavanaugh, B.C.; Dupont-Frechette, J.A.; Jerskey, B.A.; Holler, K.A. Neurocognitive deficits in children and adolescents following maltreatment: Neurodevelopmental consequences and neuropsychological implications of traumatic stress. Appl Neuropsychol Child 2017, 6, 64-78. [CrossRef]
  10. Lund, J.I.; Toombs, E.; Radford, A.; Boles, K.; Mushquash, C. Adverse childhood experiences and executive function difficulties in children: A systematic review. Child Abuse Negl 2020, 106, 104485. [CrossRef]
  11. Malarbi, S.; Abu-Rayya, H.M.; Muscara, F.; Stargatt, R. Neuropsychological functioning of childhood trauma and post-traumatic stress disorder: A meta-analysis. Neurosci Biobehav Rev 2017, 72, 68-86. [CrossRef]
  12. Masson, M.; Bussieres, E.L.; East-Richard, C.; R-Mercier, A.; Cellard, C. Neuropsychological profile of children, adolescents and adults experiencing maltreatment: A meta-analysis. Clin Neuropsychol 2015, 29, 573–594. [CrossRef]
  13. Matte-Landry, A.; Grisé Bolduc, M.È.; Tanguay-Garneau, L.; Collin-Vézina, D.; Ouellet-Morin, I. Cognitive outcomes of children with complex trauma: A systematic review and meta-analyses of longitudinal studies. Trauma Violence Abuse 2023, 24, 2743-2757. [CrossRef]
  14. Op den Kelder, R.; Van den Akker, A.L.; Geurts, H.M.; Lindauer, R.J.L.; Overbeek, G. Executive functions in trauma-exposed youth: A meta-analysis. Eur J Psychotraumatol 2018, 9, 1450595. [CrossRef]
  15. Su, Y.; D'Arcy, C.; Yuan, S.; Meng, X. How does childhood maltreatment influence ensuing cognitive functioning among people with the exposure of childhood maltreatment? A systematic review of prospective cohort studies. J Affect Disord 2019, 252, 278-293. [CrossRef]
  16. Beckett, C.; Maughan, B.; Rutter, M.; Castle, J.; Colvert, E.; Groothues, C.; Hawkins, A.; Kreppner, J.; O'Connor, T.G.; Stevens, S.; Sonuga-Barke, E.J. Scholastic attainment following severe early institutional deprivation: A study of children adopted from Romania. J Abnorm Child Psychol 2007, 35, 1063-73. [CrossRef]
  17. Bos, K.J.; Fox, N.; Zeanah, C.H.; Nelson Iii, C.A. Effects of early psychosocial deprivation on the development of memory and executive function. Front Behav Neurosci 2009, 3, 16. [CrossRef]
  18. De Bellis, M.D.; Hooper, S.R.; Spratt, E.G.; Woolley, D.P. Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. J Int Neuropsychol Soc 2009, 15, 868–878. [CrossRef]
  19. Pollak, S.D.; Nelson, C.A.; Schlaak, M.F.; Roeber, B.J.; Wewerka, S.S.; Wiik, K.L.; Frenn, K.A.; Loman, M.M.; Gunnar, M.R. Neurodevelopmental effects of early deprivation in postinstitutionalized children. Child Dev 2010, 81, 224-236. [CrossRef]
  20. Spratt, E.G.; Friedenberg, S.L.; Swenson, C.C.; Larosa, A.; De Bellis, M.D.; Macias, M.M.; Summer, A.P.; Hulsey, T.C.; Runyan, D.K.; Brady, K.T. The effects of early neglect on cognitive, language, and behavioral functioning in childhood. Psychology 2012, 3, 175-182. [CrossRef]
  21. Sylvestre, A.; Bussières, È.L.; Bouchard, C. Language problems among abused and neglected children: A meta-analytic review. Child Maltreat. 2016, 21, 47-58. [CrossRef]
  22. Johnson, D.; Policelli, J.; Li, M.; Dharamsi, A.; Hu, Q.; Sheridan, M.A.; McLaughlin, K.A.; Wade, M. Associations of early-life threat and deprivation with executive functioning in childhood and adolescence: A systematic review and meta-analysis. JAMA Pediatrics 2021, 175, e212511. [CrossRef]
  23. Danese, A.; Moffitt, T.E.; Arseneault, L.; Bleiberg, B.A.; Dinardo, P.B.; Gandelman, S.B.; Houts, R.; Ambler, A.; Fisher, H.L.; Poulton, R.; Caspi, A. The origins of cognitive deficits in victimized children: Implications for neuroscientists and clinicians. Am J Psychiatry 2017, 174, 349-361. [CrossRef]
  24. Nweze, T.; Ezenwa, M.; Ajaelu, C.; Okoye, C. Childhood mental health difficulties mediate the long-term association between early-life adversity at age 3 and poorer cognitive functioning at ages 11 and 14. J Child Psychol Psychiatry 2023, 64, 952-965. [CrossRef]
  25. Chen, R.; Williams, D.R.; Nishimi, K.; Slopen, N.; Kubzansky, L.D.; Weuve, J. A life course approach to understanding stress exposures and cognitive function among middleaged and older adults. Soc Sci Med 2022, 314, 115448. [CrossRef]
  26. Halpin, A.B.; MacAulay, R.K.; Boeve, A.R.; D'Errico, L.M.; Michaud, S. Are adverse childhood experiences associated with worse cognitive function in older adults? J Int Neuropsychol Soc 2022, 28, 1029–1038. [CrossRef]
  27. Hawkins, M.A.W.; Layman, H.M.; Ganson, K.T.; Tabler, J.; Ciciolla, L.; Tsotsoros, C.E.; Nagata, J.M. Adverse childhood events and cognitive function among young adults: Prospective results from the national longitudinal study of adolescent to adult health. Child Abuse Negl 2021, 115, 105008. [CrossRef]
  28. Nilaweera, D.; Freak-Poli, R.; Gurvich, C.; Ritchie, K.; Chaudieu, I.; Ancelin, M.L.; Ryan, J. The association between adverse childhood events and later-life cognitive function and dementia risk. J Affect Disord 2022, 304, 128–132. [CrossRef]
  29. Künzi, M.; Sieber, S.; Joly-Burra, E.; Sieber, R.; Nef, R.; Moor, C.; Zeller, A.; Bichsel, L.; Sturm, A.; Schlatter, C.; et al. Adversity specificity and life period exposure on cognitive aging. Sci Rep 2023, 13, 8702. [CrossRef]
  30. Zhang, T.; Kan, L.; Jin, C.; Shi, W. Adverse childhood experiences and their impacts on subsequent depression and cognitive impairment in Chinese adults: A nationwide multi-center study. J Affect Disord 2023, 323, 884–892. [CrossRef]
  31. Roberts, A.L.; Sumner, J.A.; Koenen, K.C.; Kubzansky, L.D.; Gilsanz, P.; Winning, A.; Rimm, E.B.; Sumner, J.A.; Okereke, O.I.; Roberts, A.L. Childhood abuse and cognitive function in a large cohort of middle-aged women. Child Maltreat 2022, 27, 100-113. [CrossRef]
  32. Feeney, J.; Kamiya, Y.; Robertson, I.H.; Kenny, R.A. Cognitive function is preserved in older adults with a reported history of childhood sexual abuse. J Trauma Stress 2013, 26, 735–743. [CrossRef]
  33. Navalta, C.P.; Polcari, A.; Webster, D.M.; Boghossian, A.; Teicher, M.H. Effects of childhood sexual abuse on neuropsychological and cognitive function in college women. J Neuropsychiatry Clin Neurosci 2006, 18, 45–53. [CrossRef]
  34. Lund, J.I.; Boles, K.; Radford, A.; Toombs, E.; Mushquash, C.J. A systematic review of childhood adversity and executive functions outcomes among adults. Arch Clin Neuropsychol 2022, 37, 1118-1132. [CrossRef]
  35. McMichael, A.J.; McGuinness, B.; Lee, J.; Minh, H.V.; Woodside, J.V.; McEvoy, C.T. Food insecurity and brain health in adults: A systematic review. Crit Rev Food Sci Nutr 2021, 62, 8728–8743. [CrossRef]
  36. Bing-Canar, H.; Stocks, J.K.; Khan, H.; Larson, S.; Duffy, M.E.; Hampstead, B.M. Adverse childhood experiences, cognitive functioning, depression, and anxiety in adulthood. Psychol Trauma 2024. [CrossRef]
  37. Grainger, S.A.; Crawford, J.D.; Kochan, N.A.; Sachdev, P.S.; Henry, J.D. An investigation into early-life stress and cognitive function in older age. Int Psychogeriatr 2020, 32, 1325-1329. [CrossRef]
  38. Montoya-Arenas, D.A.; Londoño-Guzmán, D.; Franco, J.G.; Gaviria, A.M. Effect of exposure to socio-political violence and abuse during childhood on executive planning in adult life. Front Psychiatry 2022, 12, 693741. [CrossRef]
  39. Tjoelker, F.M.; Jeuring, H.W.; Aprahamian, I.; Heeren, T.J.; Comijs, H.C. The impact of a history of child abuse on cognitive performance: a cross-sectional study in older patients with a depressive, anxiety, or somatic symptom disorder. BMC Geriatr 2022, 22, 377. [CrossRef]
  40. Donofry, S.D.; Stillman, C.M.; Hanson, J.L.; Sheridan, M.; Sun, S.; Loucks, E.B.; Erickson, K.I. Promoting brain health through physical activity among adults exposed to early life adversity: Potential mechanisms and theoretical framework. Neurosci Biobehav Rev 2021, 131, 688-703. [CrossRef]
  41. Richards, M.; Wadsworth, M.E. Long term effects of early adversity on cognitive function. Arch Dis Child 2004, 89, 922-927. [CrossRef]
  42. Wolfova, K.; Csajbok, Z.; Kagstrom, A.; Kåreholt, I.; Cermakova, P. Role of sex in the association between childhood socioeconomic position and cognitive ageing in later life. Sci Rep 2021, 11, 4647. [CrossRef]
  43. Lakkireddy, S.P.; Balachander, S.; Dayalamurthy, P.; Jayarajan, R.; Rangarajan, V.; Karthik, S.; Rao, N.P. Neurocognition and its association with adverse childhood experiences and familial risk of mental illness. Prog Neuropsychopharmacol Biol Psychiatry 2022, 119, 110620. [CrossRef]
  44. Ma, J.; Yang, Y.; Wan, Y.; Shen, C.; Qiu, P. The influence of childhood adversities on mid to late cognitive function: From the perspective of life course. PLoS One 2021, 16, e0256297. [CrossRef]
  45. Sun, Y.; Qu, S.; Li, Z.; Zhang, W.; Meng, Y.; Fang, J.; Shi, S.; Zhu, S.; Liu, N.; Song, H.; Tang, K.; Zhang, X.; Yao, Y. The mediating role of frequent mental distress in the relationship between adverse childhood experiences and cognitive disability in emerging adults. Sci Rep 2024, 14, 29717. [CrossRef]
  46. Wang, G.; Zhou, Y.; Duan, J.; Kan, Q.; Cheng, Z.; Tang, S. Effects of adverse childhood health experiences on cognitive function in Chinese middle-aged and older adults: mediating role of depression. BMC Public Health 2023, 23, 1293. [CrossRef]
  47. Lin, L.; Cao, B.; Chen, W.; Li, J.; Zhang, Y.; Guo, V.Y. Association of adverse childhood experiences and social isolation with later-life cognitive function among adults in China. JAMA Netw Open 2022, 5, e2241714. [CrossRef]
  48. O'Shea, B.Q.; Demakakos, P.; Cadar, D.; Kobayashi, L.C. Adverse childhood experiences and rate of memory decline from mid to later life: Evidence from the English Longitudinal Study of Ageing. Am J Epidemiol 2021, 190, 1294–1305. [CrossRef]
  49. Korten, N.C.; Penninx, B.W.; Pot, A.M.; Deeg, D.J.; Comijs, H.C. Adverse childhood and recent negative life events: Contrasting associations with cognitive decline in older persons. J Geriatr Psychiatry Neurol 2014, 27, 128-138. [CrossRef]
  50. Hayes-Larson, E.; Gradwohl, N.M.; Fong, J.; Kobayashi, L.C.; Gilsanz, P.; Whitmer, R.A.; Glymour, M.M.; Barnes, L.L.; Koenen, K.C.; DeCarli, C.; Fletcher, E.; Mungas, D.; Mayeda, E.R. Childhood adversity and late-life cognitive and brain health in a diverse cohort. Alzheimers Dement 2024. [CrossRef]
  51. Lor, Y.; George, K.M.; Gilsanz, P.; Mayeda, E.R.; Yaffe, K.; Whitmer, R.A. What is the association between adverse childhood experiences and late-life cognitive decline? Study of Healthy Aging in African Americans (STAR) cohort study. BMJ Open 2023, 13, e072961. [CrossRef]
  52. Huang, Z.; Jordan, J.D.; Zhang, Q. Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease. Transl Neurodegener 2023, 12, 25. [CrossRef]
  53. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801. [CrossRef]
  54. Iwasaki, A.; Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015, 16, 343-353. [CrossRef]
  55. Chrousos, G.P. Stress and disorders of the stress system. Nat Rev Endocrinol 2009, 5, 374-381. [CrossRef]
  56. Cain, D.W.; Cidlowski, J.A. Immune regulation by glucocorticoids. Nat Rev Immunol 2017, 17, 233-247. [CrossRef]
  57. Cohen, S.; Janicki-Deverts, D.; Doyle, W.J.; Miller, G.E.; Frank, E.; Rabin, B.S.; Turner, R.B. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA 2012, 109, 5995-5999. [CrossRef]
  58. Turnbull, A.V.; Rivier, C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999, 79, 1-71. [CrossRef]
  59. Gunnar, M.; Quevedo, K. The neurobiology of stress and development. Annu Rev Psychol 2007, 58, 145–173. [CrossRef]
  60. Silverman, M.N.; Sternberg, E.M. Glucocorticoid regulation of inflammation and its functional correlates: From HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 2012, 1261, 55-63.Top of Form. [CrossRef]
  61. Straub, R.H.; Cutolo, M. Glucocorticoids and chronic inflammation. Rheumatology 2016, 55, ii6-ii14. [CrossRef]
  62. Slopen, N.; Kubzansky, L.D.; McLaughlin, K.A.; Koenen, K.C. Childhood adversity and inflammatory processes in youth: A prospective study. Psychoneuroendocrinology 2013, 38, 188-200. [CrossRef]
  63. Kuhlman, K.R.; Horn, S.R.; Chiang, J.J.; Bower, J.E. Early life adversity exposure and circulating markers of inflammation in children and adolescents: A systematic review and meta-analysis. Brain Behav Immun 2020, 86, 30-42. [CrossRef]
  64. Baumeister, D.; Akhtar, R.; Ciufolini, S.; Pariante, C.M.; Mondelli, V. Childhood trauma and adulthood inflammation: A meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry 2016, 21, 642-649. [CrossRef]
  65. Brown, M.; Worrell, C.; Pariante, C.M. Inflammation and early life stress: An updated review of childhood trauma and inflammatory markers in adulthood. Pharmacol Biochem Behav 2021, 211, 173291. [CrossRef]
  66. Chiang, J.J.; Taylor, S.E.; Bower, J.E. Early adversity, neural development, and inflammation. Dev Psychobiol 2015, 57, 887-907. [CrossRef]
  67. Norton, M.C.; Hatch, D.J.; Munger, R.G.; Smith, K.R. Family member deaths in childhood predict systemic inflammation in late life. Biodemography Soc Biol 2017, 63, 104–115. [CrossRef]
  68. Giletta, M.; Slavich, G.M.; Rudolph, K.D.; Hastings, P.D.; Nock, M.K.; Prinstein, M.J. Peer victimization predicts heightened inflammatory reactivity to social stress in cognitively vulnerable adolescents. J Child Psychol Psychiatry 2017, 59, 129–139. [CrossRef]
  69. Nguyen, J.K.; Thurston, R.C. Association of childhood trauma exposure with inflammatory biomarkers among midlife women. J Womens Health 2020, 29, 1540–1546. [CrossRef]
  70. Quagliato, L.A.; Coelho, D.A.; de Matos, U.M.A.; Nardi, A.E. Physical abuse during childhood predicts IL-2R levels in adult panic disorder patients. J Affect Disord 2021, 295, 1440–1444.Top of Form. [CrossRef]
  71. Quagliato, L.A.; Nardi, A.E. The interplay between sexual abuse and inflammation, oxidative stress, and DNA damage in drug-naïve panic disorder patients. Mol Psychiatry 2023, 28, 2995–3001. [CrossRef]
  72. Finegood, E.D.; Chen, E.; Kish, J.; Vause, K.; Leigh, A.K.K.; Hoffer, L.; Miller, G.E. Community violence and cellular and cytokine indicators of inflammation in adolescents. Psychoneuroendocrinology 2020, 115, 104628. [CrossRef]
  73. Pantell, M.S.; Silveira, P.P.; de Mendonça Filho, E.J.; Wing, H.; Brown, E.M.; Keeton, V.F.; Pokhvisneva, I.; O'Donnell, K.J.; Neuhaus, J.; Hessler, D.; Meaney, M.J.; Adler, N.E.; Gottlieb, L.M. Associations between social adversity and biomarkers of inflammation, stress, and aging in children. Pediatr Res 2024. [CrossRef]
  74. Andersen, S.L. Neuroinflammation, early-life adversity, and brain development. Harv Rev Psychiatry 2022, 30, 24-39. [CrossRef]
  75. Frodl, T.; Amico, F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings? Prog Neuropsychopharmacol Biol Psychiatry 2014, 48, 295-303. [CrossRef]
  76. Ehlert, U. Enduring psychobiological effects of childhood adversity. Psychoneuroendocrinology 2013, 38, 1850–1857. [CrossRef]
  77. Teicher, M.H.; Andersen, S.L.; Polcari, A.; Anderson, C.M.; Navalta, C.P.; Kim, D.M. The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 2003, 27, 33-44. [CrossRef]
  78. Packard, C.J.; Bezlyak, V.; McLean, J.S.; Batty, G.D.; Ford, I.; Burns, H.; Cavanagh, J.; Deans, K.A.; Henderson, M.; McGinty, A.; et al. Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health 2011, 11, 1-16. [CrossRef]
  79. Davis, M.C.; Lemery-Chalfant, K.; Yeung, E.W.; Luecken, L.J.; Zautra, A.J.; Irwin, M.R. Interleukin-6 and Depressive Mood Symptoms: Mediators of the Association Between Childhood Abuse and Cognitive Performance in Middle-Aged Adults. Ann Behav Med 2019, 53, 29-38. [CrossRef]
  80. D'Amico, D.; Amestoy, M.E.; Fiocco, A.J. The mediating role of allostatic load in the relationship between early life adversity and cognitive function across the adult lifespan. Can J Aging 2022, 141, 1–11. [CrossRef]
  81. Lowry, E.; McInerney, A.; Schmitz, N.; Deschênes, S.S. Adverse childhood experiences and cognitive function in adulthood: Examining the roles of depressive symptoms and inflammation in a prospective cohort study. Soc Psychiatry Psychiatr Epidemiol 2022, 57, 2367-2377. [CrossRef]
  82. Syal, S.; Ipser, J.; Phillips, N.; Thomas, K.G.; van der Honk, J.; Stein, D.J. The effect of childhood trauma on spatial cognition in adults: a possible role of sex. Metab Brain Dis 2014, 29, 301–310. [CrossRef]
  83. Nooner, K.B.; Hooper, S.R.; De Bellis, M.D. An examination of sex differences on neurocognitive functioning and behavior problems in maltreated youth. Psychol Trauma 2018, 10, 435–443. [CrossRef]
  84. Jouriles, E.N.; Brown, A.S.; McDonald, R.; Rosenfield, D.; Leahy, M.M.; Silver, C. Intimate partner violence and preschoolers' explicit memory functioning. J Fam Psychol 2008, 22, 420–428. [CrossRef]
  85. Berthelot, N.; Paccalet, T.; Gilbert, E.; Moreau, I.; Mérette, C.; Gingras, N.; Rouleau, N.; Maziade, M. Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children. J Psychiatry Neurosci 2015, 40, 336–343. [CrossRef]
  86. Evans, G.W.; Fuller-Rowell, T.E. Childhood poverty, chronic stress, and young adult working memory: The protective role of self-regulatory capacity. Dev Sci 2013, 16, 688-96. [CrossRef]
  87. Fish, E.N. The X-files in immunity: Sex-based differences predispose immune responses. Nat Rev Immunol 2008, 8, 737-744. [CrossRef]
  88. Ngo, S.T.; Steyn, F.J.; McCombe, P.A. Gender differences in autoimmune disease. Front Neuroendocrinol 2014, 35, 347-69. [CrossRef]
  89. Gameiro, C.; Romao, F. Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2010, 2, 1299-303. [CrossRef]
  90. Baldwin, J.R.; Arseneault, L.; Caspi, A.; Fisher, H.L.; Moffitt, T.E.; Odgers, C.L.; Pariante, C.; Ambler, A.; Dove, R.; Kepa, A. Childhood victimization and inflammation in young adulthood: A genetically sensitive cohort study. Brain Behav Immun 2018, 67, 211-217.Top of Form. [CrossRef]
  91. Kim, S.; Watt, T.; Ceballos, N.; Sharma, S. Adverse childhood experiences and neuroinflammatory biomarkers-The role of sex. Stress Health 2019, 35, 432–440. [CrossRef]
  92. Pechtel, P.; Pizzagalli, D.A. Effects of early life stress on cognitive and affective function: an integrated review of human literature. Psychopharmacology 2011, 214, 55-70. [CrossRef]
  93. Doom, J.R.; Gunnar, M.R. Stress physiology and developmental psychopathology: past, present, and future. Dev Psychopathol 2013, 25, 1359-73. [CrossRef]
  94. Gurvich, C.; Thomas, N.; Kulkarni, J. Sex differences in cognition and aging and the influence of sex hormones. Handb Clin Neurol 2020, 175, 103–115. [CrossRef]
  95. Hodes, G.E.; Epperson, C.N. Sex differences in vulnerability and resilience to stress across the life span. Biol Psychiatry 2019, 86, 421–432. [CrossRef]
  96. Lupien, S.J.; McEwen, B.S.; Gunnar, M.R.; Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009, 10, 434–445. [CrossRef]
  97. Riedel, B.C.; Thompson, P.M.; Brinton, R.D. Age, APOE and sex: Triad of risk of Alzheimer's disease. J Steroid Biochem Mol Biol 2016, 160, 134-147. [CrossRef]
  98. Womersley, J.S.; Spies, G.; Seedat, S.; Hemmings, S.M.J. Childhood trauma interacts with ApoE to influence neurocognitive function in women living with HIV. J NeuroVirol 2019, 25, 183–193. [CrossRef]
  99. Kloske, C.M.; Wilcock, D.M. The important interface between apolipoprotein E and neuroinflammation in Alzheimer's Disease. Front Immunol 2020, 11, 754. [CrossRef]
  100. Comasco, E.; Gustafsson, P.A.; Sydsjö, G.; Agnafors, S.; Aho, N.; Svedin, C.G. Psychiatric symptoms in adolescents: FKBP5 genotype--early life adversity interaction effects. Eur Child Adolesc Psychiatry 2015, 24, 1473–1483. Top of Form. [CrossRef]
  101. Ke, X.; Fu, Q.; Majnik, A.; Cohen, S.; Liu, Q.; Lane, R. Adverse early life environment induces anxiety-like behavior and increases expression of FKBP5 mRNA splice variants in mouse brain. Physiol Genomics 2018, 50, 973–981. [CrossRef]
  102. Binder, E.B.; Bradley, R.G.; Liu, W.; Epstein, M.P.; Deveau, T.C.; Mercer, K.B.; Tang, Y.; Gillespie, C.F.; Heim, C.M.; Nemeroff, C.B.; et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299, 1291-1305. [CrossRef]
  103. Klengel, T.; Mehta, D.; Anacker, C. Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions. Nat Neurosci 2013, 16, 33–41. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated